25.8 C
Vientiane
Thursday, July 24, 2025
spot_img

Cision PR Newswire

Akeso Announces First Patient Enrollment in Phase III Trial of Ivonescimab for Pancreatic Cancer

HONG KONG, July 24, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a first-in-class PD-1/VEGF bispecific antibody developed by the company. The trial is investigating ivonescimab...

South Korea’s WIRobotics Takes the Spotlight at CES 2025, Plans Global Expansion

YONGIN, South Korea, Jan. 15, 2025 /PRNewswire/ -- WIRobotics, the company behind the revolutionary wearable mobility solution WIM(We Innovate Mobility), has achieved a major...

TraceLink Wins 2024 Merit Award for Technology in HealthTech Category for Second Consecutive Year

BOSTON, Jan. 15, 2025 /PRNewswire/ -- TraceLink, the largest end-to-end digital network platform for intelligent orchestration of the supply chain, is proud to announce...

BRI Distributes Rp20.33 Trillion Interim Dividend, Driving Value for Shareholders and State

JAKARTA, Indonesia, Jan. 15, 2025 /PRNewswire/ -- PT Bank Rakyat Indonesia (Persero) Tbk. (IDX: BBRI) is pleased to announce it will distribute Rp135 per...

Empowering Businesses with Agentforce: Nespon Solutions’ Real-World Use Cases

GRAPEVINE and DALLAS, Texas, Jan. 15, 2025 /PRNewswire/ -- Nespon Solutions, a Salesforce Summit Partner, is proud to introduce its latest advancements in implementing...

USPS Unveils Latest Lunar New Year Stamp

2025 is the Year of the Snake BOSTON, Jan. 15, 2025 /PRNewswire/ -- Today, the U.S. Postal Service unveiled the Lunar New Year: Year of...

APPOINTMENT OF ARVIND BHANDARI AS CHAIRMAN AND MANAGING DIRECTOR OF GOODYEAR INDIA

SHANGHAI, Jan. 15, 2025 /PRNewswire/ -- Goodyear is pleased to announce the appointment of Arvind Bhandari as Chairman and Managing Director of Goodyear India, effective...